ONTOGENETIC DEVELOPMENT OF LYMPHOCYTES
ONTOGENETIC DEVELOPMENT OF LYMPHOCYTES
批准号:
3176444
负责人:
ULRICH G HAMMERLING
金额:
$24.44万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-04-01 至 1992-03-31
关键词:
B lymphocyte RNA affinity chromatography antibody athymic mouse autoradiography biological polymorphism cell differentiation chickens clone cells crosslink electrofocusing flow cytometry gel electrophoresis gel filtration chromatography gene expression genetic manipulation genetic translation glycosylation helper T lymphocyte high performance liquid chromatography histochemistry /cytochemistry histocompatibility antigens histocompatibility gene hybridomas immunochemistry immunogenetics interferons interleukin 1 interleukin 2 isoantibody laboratory mouse leukocyte activation /transformation linkage mapping lymphocyte macrophage membrane activity membrane proteins mitogens mitomycins mixed tissue /cell culture molecular cloning monoclonal antibody nuclease nucleic acid probes phosphorylation protein structure radiotracer suppressor T lymphocyte surface antigens thymus transfection tumor necrosis factor alpha
中文摘要
Ly-6异体抗原群是细胞表面的一个例子
英文摘要
The Ly-6 group of alloantigens is one example of cell-surface
antigen systems which are encoded by multigene families. At
least five distinct Ly-6 antigens named Ly-6A, B, C, D and Th B
have been identified by us and others. Decisive progress in the
biochemical and serological characterization of these antigens
strongly supports our working hypothesis of close structural
relationships between the Ly-6 antigens. Direct support is
rendered by analysis at the DNA level with the first Ly-6 cDNA
probe available, which has confirmed the existence of multiple
cross-hybridizing Ly-6DNA sequences in the mouse genome. The
other breakthrough was the demonstration in several
laboratories, including ours, that Ly-6.A antigens are important
modulators allied with T cell activation, thus providing for the
first time clues regarding the physiological role of Ly-6 for
lymphocytes.
In view of these new developments our project on the
immunogenetics of Ly-6 will be redefined as follows: we will
1) Analyse the Ly-6A and related genes in detail,
2) Continue cellular immunological studies of Ly-6 using normal
cells and cloned cell lines to test the hypothesis that Ly-6 is a
signal modulator in cellular activation,
3) Continue the biochemical characterization of Ly-6 proteins
to determine glycosylation and phosphorylation status and their
form of plasma membrane association,
4) Look for Ly-6 involvement in multimolecular complexes on
the cell surface,
5) Following the finding that Ly-6A is selectively induced by
interferon, study modulation of Ly-6 antigen and gene expression
by lymphokines on T cell, B cells and NK cells and correlate this
with functional responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Pathway of Vitamin A Action.
-
批准号:7469998
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:6967756
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:7122785
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:7245146
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:7633156
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6230486
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6710501
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6967564
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6590998
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:7107131
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6495839
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:7233945
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6514847
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6633906
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:7417904
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:2185059
-
项目类别:
-
资助金额:$32.64万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:3307092
-
项目类别:
-
资助金额:$32.83万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:2185060
-
项目类别:
-
资助金额:$33.55万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:2185058
-
项目类别:
-
资助金额:$34.55万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
LIPID GROWTH FACTOR FOR NORMAL AND MALIGNANT B CELLS
-
批准号:2093521
-
项目类别:
-
资助金额:$24.73万
-
财政年份:1989
-
负责人:ULRICH G HAMMERLING
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: